IFNAR1 and HIV-1 infection: We have reported before that during chronic phase of HIV-1 infection in humanized mice, blockade of IFN-I signaling using a mAb targeting to IFN-I receptor (IFNAR) reduces the level of T cell activation, reverses T cell exhaustion, and improves HIV-specific CD8+ T cells (29).